CreditReports.dk
HomeScreen companies

Aptol Pharma ApS Financials, key figures and credit report

CVR number: 39308967 Established 2018 Industry: 72 Scientific research and development
Company contact details
Thad Jones Vej 6, 2450 København SV aptolpharm@gmail.com tel: 26784520 aptolpharma.com
Gross profit 2.4 kDKK FY 2024 -99.4% vs 2023
EBIT - 128.2 kDKK FY 2024 -137.5% vs 2023
Net debt -28.0 kDKK FY 2024 +82.9% vs 2023
Quick ratio 0.3 FY 2024 -0.7 vs 2023

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
External services- 137.00
Gross profit- 137.00- 421.54414.462.44
Employee benefit expenses- 304.06-72.62- 130.62
EBIT- 441.06- 421.54341.84- 128.17
Other financial income164.750.82-0.01
Other financial expenses282.79-0.13-0.24-0.00-3.11
Pre-tax profit6.47-0.13- 420.96341.84- 131.29
Income taxes-8.9486.60-33.86
Net earnings-2.46-0.13- 334.36307.98- 131.29

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables26.9420.34
Current deferred tax assets86.60
Short term receivables total26.9486.6020.34
Cash and bank deposits50.000.0017.05163.4428.01
Cash and cash equivalents50.000.0017.05163.4428.01
Balance sheet total (assets)50.0026.94103.64163.4448.35

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital50.0050.0050.0050.0050.00
Retained earnings2.46-32.54-32.66- 367.03-59.05
Profit of the financial year-2.46-0.13- 334.36307.98- 131.29
Shareholders equity total50.0017.34- 317.03-9.05- 140.34
Non-current liabilities total
Current trade creditors393.63
Short-term deferred tax liabilities33.8636.46
Other non-interest bearing current liabilities9.6127.04138.62152.22
Current liabilities total9.61420.67172.48188.68
Balance sheet total (liabilities)50.0026.94103.64163.4448.35
Page generated